• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人巩膜通透性。年龄、冷冻疗法、经巩膜二极管激光及手术变薄的影响。

Human scleral permeability. Effects of age, cryotherapy, transscleral diode laser, and surgical thinning.

作者信息

Olsen T W, Edelhauser H F, Lim J I, Geroski D H

机构信息

Department of Ophthalmology, Emory University, Atlanta, GA 30322, USA.

出版信息

Invest Ophthalmol Vis Sci. 1995 Aug;36(9):1893-903.

PMID:7543465
Abstract

PURPOSE

To determine the in vitro permeability of human sclera to compounds varying in molecular weight. To evaluate the effects of age, cryotherapy, transscleral diode laser, and surgical thinning on scleral permeability.

METHODS

Scleral tissue from 97 human eye bank eyes was tested individually in a two-chamber Ussing apparatus with the following hydrophilic radiolabeled compounds on one side of the chamber: 5-fluorouracil, sucrose, dexamethasone, methotrexate, inulin, and three separate dextran polymers (MWt = 10,000, 40,000, and 70,000). Scleral hydration levels were obtained on 20 more scleral specimens. Additional groups of scleral specimens were treated with either a cryotherapy probe, a transscleral diode laser retinopexy probe, or partial thickness lamellar dissection, and specimens were mounted in the Ussing chambers for testing. Scleral tissue was digested to measure the amount of radioactivity present. Scleral sections were examined with electron microscopy.

RESULTS

Scleral hydration was maintained during the perfusion. The mean scleral permeability (cm/second x 10(-6) +/- SD) was established for each of the above compounds. Age, cryotherapy, or diode laser treatment did not alter permeability or ultrastructure of the sclera. Surgical thinning significantly increased the scleral permeability to dexamethasone (P = 0.011) and methotrexate (P = 0.037).

CONCLUSION

This study establishes baseline human scleral permeability to a series of hydrophilic compounds with various molecular weights. Age, cryotherapy, and diode laser treatment do not alter the permeability or ultrastructure of the sclera, whereas surgical thinning significantly increases permeability.

摘要

目的

确定人巩膜对不同分子量化合物的体外通透性。评估年龄、冷冻疗法、经巩膜二极管激光以及手术变薄对巩膜通透性的影响。

方法

在双室Ussing装置中对97只人眼库眼球的巩膜组织进行单独测试,在腔室一侧放置以下亲水性放射性标记化合物:5-氟尿嘧啶、蔗糖、地塞米松、甲氨蝶呤、菊粉以及三种不同的葡聚糖聚合物(分子量分别为10,000、40,000和70,000)。对另外20个巩膜标本测定巩膜水化水平。将额外的巩膜标本组分别用冷冻疗法探头、经巩膜二极管激光视网膜固定探头或部分厚度板层剥离进行处理,然后将标本安装在Ussing腔室中进行测试。消化巩膜组织以测量其中存在的放射性量。用电子显微镜检查巩膜切片。

结果

灌注过程中巩膜水化得以维持。确定了上述每种化合物的平均巩膜通透性(厘米/秒×10⁻⁶±标准差)。年龄、冷冻疗法或二极管激光治疗均未改变巩膜的通透性或超微结构。手术变薄显著增加了巩膜对地塞米松(P = 0.011)和甲氨蝶呤(P = 0.037)的通透性。

结论

本研究确立了人巩膜对一系列不同分子量亲水性化合物的基线通透性。年龄、冷冻疗法和二极管激光治疗不会改变巩膜的通透性或超微结构,而手术变薄则会显著增加通透性。

相似文献

1
Human scleral permeability. Effects of age, cryotherapy, transscleral diode laser, and surgical thinning.人巩膜通透性。年龄、冷冻疗法、经巩膜二极管激光及手术变薄的影响。
Invest Ophthalmol Vis Sci. 1995 Aug;36(9):1893-903.
2
Diffusion of high molecular weight compounds through sclera.高分子量化合物通过巩膜的扩散。
Invest Ophthalmol Vis Sci. 2000 Apr;41(5):1181-5.
3
Human scleral hydraulic conductivity: age-related changes, topographical variation, and potential scleral outflow facility.人巩膜水导率:与年龄相关的变化、地形变化及潜在的巩膜流出率
Invest Ophthalmol Vis Sci. 2006 Nov;47(11):4942-6. doi: 10.1167/iovs.06-0362.
4
Increased human scleral permeability with prostaglandin exposure.前列腺素暴露会增加人巩膜通透性。
Invest Ophthalmol Vis Sci. 2001 Jun;42(7):1514-21.
5
Multicenter trial of transscleral diode laser retinopexy in retinal detachment surgery.经巩膜二极管激光视网膜光凝术在视网膜脱离手术中的多中心试验
Trans Am Ophthalmol Soc. 1997;95:221-30.
6
The influence of intraocular pressure on the transscleral diffusion of high-molecular-weight compounds.眼压对高分子量化合物经巩膜扩散的影响。
Invest Ophthalmol Vis Sci. 2005 Oct;46(10):3790-4. doi: 10.1167/iovs.04-1414.
7
Scleral hydraulic conductivity and macromolecular diffusion in patients with uveal effusion syndrome.葡萄膜渗漏综合征患者的巩膜水导率和大分子扩散
Invest Ophthalmol Vis Sci. 2008 Nov;49(11):5033-40. doi: 10.1167/iovs.08-1980. Epub 2008 Jun 14.
8
In vitro human scleral permeability of fluorescein, dexamethasone-fluorescein, methotrexate-fluorescein and rhodamine 6G and the use of a coated coil as a new drug delivery system.荧光素、地塞米松 - 荧光素、甲氨蝶呤 - 荧光素和罗丹明6G在体外人巩膜中的通透性以及使用包被线圈作为一种新型药物递送系统的研究
J Ocul Pharmacol Ther. 2002 Dec;18(6):559-69. doi: 10.1089/108076802321021108.
9
Enhanced FGF-2 movement through human sclera after exposure to latanoprost.暴露于拉坦前列素后,FGF-2通过人巩膜的运动增强。
Invest Ophthalmol Vis Sci. 2001 Oct;42(11):2554-9.
10
Diffusion of macromolecules through sclera.大分子通过巩膜的扩散。
Acta Ophthalmol. 2013 Feb;91(1):e1-6. doi: 10.1111/j.1755-3768.2012.02557.x. Epub 2012 Sep 23.

引用本文的文献

1
Bio-interventional Uveoscleral Outflow Enhancement Surgery for Primary Open-Angle Glaucoma: 2-Year Results of Cyclodialysis with Scleral Allograft Reinforcement.用于原发性开角型青光眼的生物介入性葡萄膜巩膜引流增强手术:巩膜同种异体移植强化睫状体分离术的2年结果
Ophthalmol Sci. 2025 Feb 3;5(4):100727. doi: 10.1016/j.xops.2025.100727. eCollection 2025 Jul-Aug.
2
Pulsed Ultrasound-Mediated Drug Delivery Enhancement Through Human Sclera.脉冲超声介导药物透过人巩膜递送的增强作用
Transl Vis Sci Technol. 2025 Jan 2;14(1):7. doi: 10.1167/tvst.14.1.7.
3
Nanomedicine in Ophthalmology: From Bench to Bedside.
眼科纳米医学:从实验台到病床边
J Clin Med. 2024 Dec 16;13(24):7651. doi: 10.3390/jcm13247651.
4
Innovative Nanotechnology in Drug Delivery Systems for Advanced Treatment of Posterior Segment Ocular Diseases.创新型纳米技术在药物输送系统中的应用:用于后节眼部疾病的高级治疗。
Adv Sci (Weinh). 2024 Aug;11(32):e2403399. doi: 10.1002/advs.202403399. Epub 2024 Jun 21.
5
The Evolving Surgical Paradigm of Scleral Allograft Bio-Tissue Use in Ophthalmic Surgery: Techniques and Clinical Indications for Ab-Externo and Ab-Interno Scleral Reinforcement.眼科手术中同种异体巩膜生物组织应用的不断演变的手术模式:外路和内路巩膜加固术的技术与临床适应症
Clin Ophthalmol. 2024 Jun 21;18:1789-1795. doi: 10.2147/OPTH.S462719. eCollection 2024.
6
Posterior eye delivery of angiogenesis-inhibiting RNA nanoparticles via subconjunctival injection.经结膜下注射递送至眼后段的血管生成抑制 RNA 纳米颗粒。
Int J Pharm. 2024 May 25;657:124151. doi: 10.1016/j.ijpharm.2024.124151. Epub 2024 Apr 23.
7
Extracellular vesicle encapsulated nicotinamide delivered via a trans-scleral route provides retinal ganglion cell neuroprotection.经巩膜途径递送的细胞外囊泡包裹烟酰胺可提供视网膜神经节细胞保护。
Acta Neuropathol Commun. 2024 Apr 22;12(1):65. doi: 10.1186/s40478-024-01777-0.
8
Ocular Delivery of Therapeutic Proteins: A Review.治疗性蛋白质的眼部给药:综述
Pharmaceutics. 2023 Jan 6;15(1):205. doi: 10.3390/pharmaceutics15010205.
9
Non-Viral Delivery of CRISPR/Cas Cargo to the Retina Using Nanoparticles: Current Possibilities, Challenges, and Limitations.使用纳米颗粒将CRISPR/Cas物质非病毒递送至视网膜:当前的可能性、挑战及局限性
Pharmaceutics. 2022 Sep 1;14(9):1842. doi: 10.3390/pharmaceutics14091842.
10
Ocular Barriers and Their Influence on Gene Therapy Products Delivery.眼部屏障及其对基因治疗产品递送的影响。
Pharmaceutics. 2022 May 6;14(5):998. doi: 10.3390/pharmaceutics14050998.